Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Bar

Showing results (11-20 of 101) with videos related to

Pageof 11
Sort By:
Blood Reviews|November 4, 2019
JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemiaSangeetha Venugopal, Michal Bar-Natan, John O Mascarenhas
Seminars in Arthritis and Rheumatism|January 16, 2003
Sternoclavicular infectious arthritis in previously healthy adultsMichal Bar-Natan, Moshe Salai, Yechezkel Sidi, et al.
Journal of Cardiovascular Development and Disease|January 24, 2025
The e-STROKE Study: The Design of a Prospective Observational Multicentral StudyKateřina Dvorníková, Veronika Kunešová, Svatopluk Ostrý, et al.
European Journal of Dermatology : EJD|September 21, 2005
Confirmation of the association between male pattern baldness and the androgen receptor geneEtgar Levy-Nissenbaum, Michal Bar-Natan, Moshe Frydman, et al.
Acta Ophthalmologica|July 12, 2008
Colour Doppler imaging evaluation of blood flow parameters in the ophthalmic artery in acute and chronic phases of optic neuritis in multiple sclerosisPavel Hradílek, Pavel Stourac, Michal Bar, et al.
Blood Reviews|March 9, 2023
'Secondary' acute lymphoblastic/lymphocytic leukemia - done playing second fiddle?Yosef Joseph Rene Amel Riazat-Kesh, John Mascarenhas, Michal Bar-Natan
JAK-STAT|September 24, 2013
STAT signaling in the pathogenesis and treatment of myeloid malignanciesMichal Bar-Natan, Erik A Nelson, Michael Xiang, et al.
Expert Review of Hematology|January 15, 2014
Immunotherapy for multiple myelomaJacalyn Rosenblatt, Michal Bar-Natan, Nikhil C Munshi, et al.
Journal of Immunological Methods|June 15, 2017
A signal amplification probe enhances sensitivity of antibodies and aptamers based Immuno-diagnostic assaysOfer Nussbaum, Michal Bar Oz, Tal Tilayov, et al.
Omega|June 24, 2020
The Attitudes of Progressive Neurological Disease Patients and Their Family Members to End of Life Care: A Cross-Sectional StudyRadka Bužgová, Radka Kozáková, Michal Bar, et al.
Pageof 11

Showing results (11-20 of 101) with videos related to

Sort By:
Pageof 11
Blood Reviews|November 4, 2019
JAKs to STATs: A tantalizing therapeutic target in acute myeloid leukemiaSangeetha Venugopal, Michal Bar-Natan, John O Mascarenhas
Seminars in Arthritis and Rheumatism|January 16, 2003
Sternoclavicular infectious arthritis in previously healthy adultsMichal Bar-Natan, Moshe Salai, Yechezkel Sidi, et al.
Journal of Cardiovascular Development and Disease|January 24, 2025
The e-STROKE Study: The Design of a Prospective Observational Multicentral StudyKateřina Dvorníková, Veronika Kunešová, Svatopluk Ostrý, et al.
European Journal of Dermatology : EJD|September 21, 2005
Confirmation of the association between male pattern baldness and the androgen receptor geneEtgar Levy-Nissenbaum, Michal Bar-Natan, Moshe Frydman, et al.
Acta Ophthalmologica|July 12, 2008
Colour Doppler imaging evaluation of blood flow parameters in the ophthalmic artery in acute and chronic phases of optic neuritis in multiple sclerosisPavel Hradílek, Pavel Stourac, Michal Bar, et al.
Blood Reviews|March 9, 2023
'Secondary' acute lymphoblastic/lymphocytic leukemia - done playing second fiddle?Yosef Joseph Rene Amel Riazat-Kesh, John Mascarenhas, Michal Bar-Natan
JAK-STAT|September 24, 2013
STAT signaling in the pathogenesis and treatment of myeloid malignanciesMichal Bar-Natan, Erik A Nelson, Michael Xiang, et al.
Expert Review of Hematology|January 15, 2014
Immunotherapy for multiple myelomaJacalyn Rosenblatt, Michal Bar-Natan, Nikhil C Munshi, et al.
Journal of Immunological Methods|June 15, 2017
A signal amplification probe enhances sensitivity of antibodies and aptamers based Immuno-diagnostic assaysOfer Nussbaum, Michal Bar Oz, Tal Tilayov, et al.
Omega|June 24, 2020
The Attitudes of Progressive Neurological Disease Patients and Their Family Members to End of Life Care: A Cross-Sectional StudyRadka Bužgová, Radka Kozáková, Michal Bar, et al.
Pageof 11